How insurance affects cancer survival rates

Also: A chill with China-U.S. drug partnerships

July 8, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | Survival rates for cancer patients on immunotherapy depend on insurance coverage, study finds "Health insurance coverage is one of the strongest predictors of access to cancer care and survival following a cancer diagnosis," says study's lead author. By Marissa Russo STAT+ | As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment A pair of recent announcements by the FDA suggest the agency is focused on national political priorities and has a suspicion of 'hostile countries.' By Brian Yang Opinion: How the U.S. health care system fails cancer patients like former MTV VJ Ananda Lewis Cancer patients like Ananda Lewis turn to "natural therapies" because of fear, confusion, and a sense that no one in the system is looking out for them. By Samyukta Mullangi Jose Luis Magana/AP STAT+ | Inside the staff exodus and tanking morale that threaten Makary's FDA FDA staff are already missing deadlines, and the future consequences could be even more dire as workers head for the exits. By Lizzy Lawrence

More around STAT

---

More reads Lung cancer screening on wheels, New York Times Summit Therapeutics is in talks for $15 billion partnership with AstraZeneca, Bloomberg From April 2025: Will the FDA approve the first new drug to help people quit smoking in 20 years? STAT

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser